Categories: News

Sharecare to present at 40th Annual J.P. Morgan Healthcare Conference

ATLANTA, Dec. 21, 2021 /PRNewswire/ — Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that its chairman and CEO, Jeff Arnold, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022 at 2:15 p.m. EST.

A live audio webcast and replay of the event will be available online at https://investors.sharecare.com/news-and-events/events-and-presentations.

About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Media Relations:
Jen Martin Hall
jen@sharecare.com 

Investor Relations:
Evan Smith, CFA
evan.smith@sharecare.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/sharecare-to-present-at-40th-annual-jp-morgan-healthcare-conference-301448812.html

SOURCE Sharecare

Staff

Recent Posts

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…

3 hours ago

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

5 hours ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

5 hours ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

8 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

11 hours ago